High health insurance deductibles, physician charges, medication expenses spur patients to seek less costly lab testing, surgical procedures, prescription drugs
Search results for: prescription drug prices
What the Affordable Care Act Means for Rheumatology
Expected to flood the healthcare system with an influx of insured patients, Obamacare will likely exacerbate physician shortages, worsen capacity issues for many rheumatologists, and pressure providers to deliver a measurable quality of care, but analysts say rheumatology patients will benefit from expanded insurance coverage options
Rheuminations: New Rules for Rheumatologists
Transparent hospital costs, salary caps for senior hospital executives, and no more faxes top one rheumatologist’s wish list for revised healthcare rules
No Easy Solution for Lack of Transparency in the Practice of Medicine
Several well-publicized episodes highlight the apparent lack of disclosure of conflicts of interest in medicine, but will disclosure laws fix the problem or add to the confusion?
Rheumatology’s Virtual “Water Cooler”
The ACR list serves allow rheumatologists and health professionals across the country to connect and share ideas
Colcrys Approval Triggers Questions
Some rheumatologists question the depth of research and the approval’s implications for patient access
The Law of Unintended Consequences Rears Its Head
A program to improve drug safety has increased drug prices for patients with gout and FMF
The Symptoms or the Disease
Where should we focus?
Medicare Switch to ASP Pricing Reduces Part B Spending
The Medicare Payment Advisory Commission (MedPAC) reported to Congress in January that Medicare’s switch to a payment method known as ASP, or Average Sale Price, has reduced spending on drugs in the Medicare Part B program. This system reflects actual market spending, rather than wholesale prices.
Medicare D-lemmas
Rheumatologists and patients report mixed experiences with the new prescription drug benefit
- « Previous Page
- 1
- …
- 11
- 12
- 13